Skip to content
Search

Latest Stories

NHS chief announces new campaign for early detection of cancer

NHS chief executive Amanda Pritchard today (March 1) announced a new campaign to promote early detection of cancer, when it is easier to treat.

The campaign, which would run across TV, radio, and social media from Wednesday (March 2), is the first to focus on tackling the fear of cancer rather than specific symptoms.


It is in line with the NHS Long Term Plan’s commitment to increase cancer detection at an early stage by 2028.

As per the NHS figures, the number of people getting checked for cancer increased by over half a million between December 2020 and December 2021.

NHS chief Amanda Pritchard Chief Executive of NHS England Amanda Pritchard (Photo by Tom Nicholson-WPA Pool/Getty Images)

Speaking ahead of the launch, Pritchard, said: “We know that the prospect of a cancer diagnosis can be daunting for people and that is exactly why we are launching this potentially lifesaving campaign – we want to allay people’s fear about cancer and encourage them to get checked without delay.

“We know that many people don’t want to burden or bother anyone with their health concerns, but we would always prefer to see you sooner with a cancer that is easier to treat, than later with one that isn’t.”

She noted that cancer treatment was prioritized during the pandemic with over half a million people starting treatment over the last two years.

“So, the NHS is here for you – don’t let cancer play on your mind – get checked without delay”.

Besides NHS bosses, cancer charities are urging people not to delay “lifesaving” checks, highlighting nine in ten of those checked turn out not to have cancer.

However, an early detection is important so that people can get treated early when chances of survival are highest.

Sajid Javid Health secretary Sajid Javid

Health and social care secretary, Sajid Javid said: “Having lost my father to cancer I know how worrying the prospect of a cancer diagnosis can be for people and their families.

“We want to tackle these fears head on and the message of this campaign is clear – it’s always better to get checked than delay. Coming forward can give you much needed certainty, and the earlier we catch cancer, the more lives we can save.

“We’re committed to making sure people get the care and treatment they need, which is why I’ve declared a national war on cancer with and we are developing a new 10 year plan focussing on innovative treatments and early diagnosis”.

More For You

Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less